全文获取类型
收费全文 | 1409篇 |
免费 | 76篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 59篇 |
妇产科学 | 68篇 |
基础医学 | 138篇 |
口腔科学 | 76篇 |
临床医学 | 118篇 |
内科学 | 239篇 |
皮肤病学 | 34篇 |
神经病学 | 96篇 |
特种医学 | 60篇 |
外科学 | 256篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 40篇 |
眼科学 | 88篇 |
药学 | 77篇 |
中国医学 | 7篇 |
肿瘤学 | 75篇 |
出版年
2023年 | 20篇 |
2022年 | 26篇 |
2021年 | 60篇 |
2020年 | 33篇 |
2019年 | 39篇 |
2018年 | 44篇 |
2017年 | 34篇 |
2016年 | 59篇 |
2015年 | 57篇 |
2014年 | 41篇 |
2013年 | 74篇 |
2012年 | 105篇 |
2011年 | 100篇 |
2010年 | 72篇 |
2009年 | 61篇 |
2008年 | 102篇 |
2007年 | 90篇 |
2006年 | 87篇 |
2005年 | 75篇 |
2004年 | 74篇 |
2003年 | 53篇 |
2002年 | 49篇 |
2001年 | 24篇 |
2000年 | 16篇 |
1999年 | 12篇 |
1998年 | 5篇 |
1997年 | 8篇 |
1996年 | 3篇 |
1995年 | 6篇 |
1994年 | 1篇 |
1993年 | 4篇 |
1992年 | 3篇 |
1991年 | 1篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 9篇 |
1987年 | 11篇 |
1986年 | 6篇 |
1985年 | 1篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1968年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有1492条查询结果,搜索用时 15 毫秒
11.
12.
Ilknur I Bütün Hakan Ekmek?i Hüseyin S?nmez Ci?dem Gürel Ozlem Cift?i Turgut Ulutin Emine K?ko?lu Nergiz Domani? Ahmet Dirican 《Clinical and applied thrombosis/hemostasis》2007,13(3):308-312
Several studies indicate that thrombosis plays an important role in the pathogenesis of coronary heart disease (CHD). Fibronectin is a multifunctional protein in plasma, other body fluids, and cell surface and plays an important role in platelet functions, including mediation of cell-cell and cell-surface interactions. Sialic acid is a regular constituent of glycoproteins and gangliozides in the outer cell membrane of mammalian cells. Therefore, the sialic acid content of platelets, which are characterized by their ability to aggregate with each other, can be important in leading to thrombus formation. In this study, platelet fibronectin, sialic acid-, and adenosine diphosphate (ADP)-induced platelet aggregation levels were determined in patients with CHD. Platelet sialic acid concentrations were determined by Warren's method. Platelet aggregation tests with ADP in platelet-rich plasma (PRP) were analyzed by use of an aggregometer. Platelet homogenate fibronectin levels were determined by ELISA. Total protein levels were determined by Lowry method. Our results indicate that, in patients with no vessel disease (patients with no obstructed vessel but suffering from chest pain, like angina pectoris) platelet fibronectin levels were significantly lower than the total of the other patients (patients with 1, 2, or 3 obstructed coronary vessels) (p<0.05). Sialic acid levels in patients with no vessel disease were significantly lower than the total of the patient group (p<0.05). There was significant (+) correlation between platelet aggregation, platelet fibronectin, platelet sialic acid, and severity of disease (p<0.05). Our preliminary findings suggest that, especially platelet fibronectin levels potentially represent a pathogenic factor for CHD. 相似文献
13.
Jargalsaikhan Dagvadorj Karolina Mikulska-Ruminska Gantsetseg Tumurkhuu Rojo A. Ratsimandresy Jessica Carriere Allen M. Andres Stefanie Marek-Iannucci Yang Song Shuang Chen Malcolm Lane Andrea Dorfleutner Roberta A. Gottlieb Christian Stehlik Suzanne Cassel Fayyaz S. Sutterwala Ivet Bahar Timothy R. Crother Moshe Arditi 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(1)
14.
15.
Vikas Kumar Kalicharan Sharma Bahar Ahmed F. A. Al-Abbasi Firoz Anwar Amita Verma 《RSC advances》2018,8(32):18180
Wedelia calendulacea has a long history of use in the Indian Ayurvedic System of Medicine for the treatment, prevention, and cure of a diverse range of human diseases such as diabetes obesity, and other metabolic diseases. A wide range of chemical constituents, such as triterpenoid saponin, kauren diterpene, and coumestans, has been isolated from the plant. Conversely, no published literature is available in relation to the isolation of wedelolactone (WEL) for its anti-diabetic effect. The aim of the present study was to isolate the bioactive phyto-constituent from Wedelia calendulacea and to scrutinize the antidiabetic effect with its possible mechanism of action. The structure of the isolated compound was elucidated by different spectroscopy techniques. Proteins, such as dipeptidyl peptidase-4 (DPPIV), glucose transporter 1 (GLUT1), and peroxisome proliferator-activated receptors-γ (PPARγ), were also subjected to in silico docking. Later, this isolated compound was scrutinized against α-glucosidase and α-amylase enzyme activity along with an oral glucose tolerance test (OGTT) for estimation of glucose utilization. Streptozotocin (STZ) was used for the induction of type II diabetes mellitus (DM) in Wistar rats. The rats were divided into different groups and received the WEL (5, 10, and 20 mg kg−1, b.w.) and glibenclamide (2.5 mg kg−1, b.w.) for 28 days. The blood glucose level (BGL), plasma insulin, and body weight were determined at regular time intervals. The serum lipid profile hypolipidemic effect for the different antioxidant markers and hepatic tissue markers were scrutinized along with an inflammatory mediator to deduce the possible mechanism. With the help of spectroscopy techniques, the isolated compound was identified as wedelolactone. In the docking study, WEL showed docking scores of −6.17, −9.43, and −7.66 against DPP4, GLUTI, and PRARY, respectively. WEL showed the inhibition of α-glucosidase (80.65%) and α-amylase (93.83%) and suggested an effect on postprandial hyperglycemia. In the OGTT, WEL significantly (P < 0.001) downregulated the BGL, a marker for better utilization of drugs. In the diabetes model, WEL reduced the BGL and enhanced the plasma insulin and body weight. It also significantly (P < 0.001) modulated the lipid profile; this suggested an anti-hyperlipidemia effect. WEL significantly (P < 0.001) distorted the hepatic tissue, acting as an antioxidant marker in a dose-dependent manner. WEL significantly (P < 0.001) downregulated the C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), and interleukin 6 (IL-6) level. On the basis of the available results, we can conclude that WEL can be an alternative drug for the treatment of type II DM either by inhibiting the production of inflammatory mediator or by the downregulation of oxidative stress. Wedelia calendulacea has a long history of use in the Indian Ayurvedic System of Medicine for the treatment, prevention, and cure of a diverse range of human diseases such as diabetes obesity, and other metabolic diseases. 相似文献
16.
Sezgin M Demirel AC Karaca C Ortancil O Ulkar GB Kanik A Cakçi A 《Rheumatology international》2005,25(4):264-269
Our aim was to investigate the effects of hyaluronan on inflammatory cytokines in the synovial fluid of patients with knee osteoarthritis. The study was single blind, placebo-controlled, and randomized. We administered hyaluronan to 22 patients in the study group and placebo to 19 in the control group. Enzyme-linked immunosorbent assay was used to determine the levels of cytokines. Both HA and placebo caused a significant decrease in interleukin (IL)-6 levels (P=0.0001 and P=0.04, respectively). But it was more significant in the study group. However, IL-8 and tumor necrosis factor alpha (TNF-) levels did not change in either group (P>0.05). The amount of effusion decreased significantly in the study group (P=0.001) but not in the control group (P=0.133). It can be concluded that hyaluronan considerably decreased IL-6 levels, which correlated with clinical improvement, but had no effect on IL-8 and TNF- levels in synovial fluid. However, larger studies with longer follow-up periods are needed to explain the effect of hyaluronan on cytokines. 相似文献
17.
18.
19.
20.
There is an increasing recognition of the association between chronic hepatitis C virus (HCV) infection and glomerular diseases.
Renal complications may be the presenting manifestation of HCV infection. Patients may present with systemic vasculitis secondary
to cryoglobulinemia, or they may present with proteinuria, microscopic hematuria, acute renal failure, or nephrotic syndrome.
The pathogenesis of HCV-associated renal disease remains incompletely understood; however, deposition of HCV-containing circulating
immune complexes in the glomeruli (ie, subendothelial space and mesangium) seems to play an important role. The most common
renal pathology associated with HCV infection is type I membranoproliferative glomerulonephritis with or without cryoglobulinemia.
In patients who do not have significant renal impairment, combination therapy with interferon-á and ribavirin is the treatment
of choice. The experience with this combination therapy is quite limited in patients with renal impairment. Prolonged courses
of high-dose interferon-á therapy have been successfully used for these patients; however, relapse of HCV viremia and recurrence
of renal disease is common after discontinuation of therapy. 相似文献